Polymorphisms in XRCC1 and ERCC4/XPF DNA repair genes and associations with breast cancer risk in women;Polimorfizmy genów XRCC1 i ERCC4/XPF uczestnicza̧cych w naprawie DNA oraz ich wpływ na ryzyko powstawania raka piersi u kobiet

Polski Merkuriusz Lekarski

Volumn 22, Issue 129, 2007, Pages 200-203

  Romanowicz Makowska, Hanna ^a,b   Smolarz, Beata ^a,b   Kulig, Andrzej ^a,b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b INSTITUTE OF TUBERCULOSIS AND LUNG DISEASES   (Poland)

Author keywords

Breast cancer; DNA repair genes; Gene polymorphism

Indexed keywords

DNA; DNA BINDING PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XERODERMA PIGMENTOSUM GROUP F PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; BREAST; BREAST TUMOR; CARCINOMA; CASE CONTROL STUDY; DNA REPAIR; EVALUATION; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA; CASE-CONTROL STUDIES; DNA; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 34047106908     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aquilina G., Bignami M.: Mismatch repair in correction of replication errors and processing of DNA damage. J. Cell Physiol, 2001, 187, 145-154.
2. Bessho T., Sancar A., Thompson L.H. i wsp.: Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J. Biol. Chem., 1997, 272, 3833-3837.
3. Bishop D.K., Ear U., Bhattacharyya A. i wsp.: Xrcc3 is required for assembly of Rad51 complexes in vivo. J. Biol. Chem., 1998, 273, 21482-21488.
4. Chacko P., Rajan B., Joseph T. i wsp.: Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res. Treat., 2005, 89, 15-21.
5. Chang-Claude J., Popanda O., Tan X.L. i wsp.: Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin. Cancer Res., 2005, 11, 4802-4809.
6. Duell E.J., Milikan R.C., Pitman G.S. i wsp.: Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol. Biomark. Prev., 2001, 10, 217-222.
7. Fu Y.P., Yu J.C., Cheng T.C. i wsp.: Breast Cancer risk associated with genotypic polymorphism of the nonhomologous endjoining genes. Cancer Res., 2003, 63, 2440-2446.
8. Goode E.L., Ulrich C.M., Potter J.D.: Polymorphisms in DNA Repair Genes and Associations with Cancer Risk. Cancer Epidemiol. Biomark. Prev., 2002, 11, 1513-1530.
9. Khanna K.K., Jackson S.P.: DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet., 2001, 27, 247-254.
10. Kuschel B., Auranen A., McBride S. i wsp.: Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet., 2002, 11, 1399-407.
11. Lee J.M., Lee Y.C., Yang S.Y. i wsp.: Genetic polymorphism of XRCC1 and risk of the esophageal cancer. Int. J. Cancer., 2001, 95, 240-246.
12. Lengauer C., Kinzler K., Vogelstain B.: Genetic instabilities in human cancers. Nature, 1998, 396, 643-649.
13. McGuire W., Clark G.M.: Prognostic factors and treatment decisions in axillary node-negative breast cancer. N. Engl. J. Med., 1992, 326, 1756-1761.
14. Metsola K., Kataja V., Sillanpaa P. i wsp.: XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res., 2005, 7, 987-997.
15. Nelson H., Kelsey K., Mott L. i wsp.: The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-enviroment interaction. Cancer Res., 2002, 62, 152-155.
16. Ravaioli A., Bagli L., Zucchini A. i wsp.: Prognosis and prediction of response in breast cancer. The current role of the main biological markers. Cell Proliferation, 1998, 31, 113-126.
17. Roberts R.J., Cheng X.: Base flipping. Ann. Rev. Biochem., 1998, 67, 181-198.
18. Romanowicz-Makowska H., Smolarz B., Kulig A.: The G/C polymorphism of RAD51 gene in breast cancer. Pol. Merkuriusz Lek., 2006, 21, 55-58.
19. Romanowicz-Makowska H., Smolarz B., Zadrozny M. i wsp.: Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer. Exp. Oncol., 2006, 28, 156-159.
20. Shi Q., Wang Li-E., Bondy M. i wsp.: Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis, 2004, 25, 1695-1700.
21. Shen M., Hung R.J., Brennan P. i wsp.: Polymorphisms of DNA Repair Genes XRCC1, XRCC3, XPD, Interaction with environmental exposures, and bladder cancer risk in a case-control study in Northern Italy. Cancer Epidemiol. Biomark. Prev., 2003, 12, 1234-1240.
22. Shen H., Xu Y., Qian Y i wsp.: Polymorphism of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int. J. Cancer, 2000, 88, 601-606.
23. Smith T.R., Levine E.A., Perrier N.D. i wsp.: DNA-repair genetic polymorphism and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 2003, 12, 1200-1204.
24. Sobol R.W., Horton J.K., Kuhn R. i wsp.: Requirement of mammalian DNA polymerase-β in base excision repair. Nature, 1996, 379, 183-186.
25. Spencer C.C.: Human polymorphism around recombination hotspots. Biochem. Soc. Trans., 2006, 34, 535-536.
26. Stern M.C., Umbach D.M., van Gills C.H. i wsp.: DNA repair gene XRCC1 polymorphism, smoking and bladder cancer risk. Cancer Epidemiol. Biomark Prev., 2001, 10, 125-131.
27. Thompson L.H., West M.G.: XRCC1 keeps DNA from getting stranded. Mutat. Res., 2000, 459, 1-18.
28. Webb P.M., Hopper J.L., Newman B. i wsp.: Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol. Biomark. Prev., 2005, 14, 319-323.
29. Vispe S., Yung T.M., Ritchot J. i wsp.: A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage. Proc. Natl. Acad. Sci. USA. 200, 97, 9886-9891.
30. Zhai X., Liu J., Hu Z., Wang S. i wsp.: Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis. Oncol. Rep., 2006, 15, 247-252.